Patent details
EP1339409 Title: USE OF ROSUVASTATIN (ZD-4522) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Basic Information
- Publication number:
- EP1339409
- PCT Application Number:
- PCT/GB/2001/005041
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP019826239
- PCT Publication Number:
- WO/2002/041895
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF ROSUVASTATIN (ZD-4522) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
- French Title of Invention:
- UTILISATION DE LA ROSUVASTATINE (ZD-4522) DANS LE TRAITEMENT DE L'HYPERCHOLESTEROLEMIE FAMILIALE
- German Title of Invention:
- VERWENDUNG VON ROSUVASTATIN (ZD-4522) ZUR BEHANDLUNG VON HETEROZYGOTER FAMILIÄRER HYPERCHOLESTEROLÄMIE
- SPC Number:
Dates
- Filing date:
- 16/11/2001
- Grant date:
- 07/05/2008
- EP Publication Date:
- 07/05/2008
- PCT Publication Date:
- 30/05/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/09/2003
- EP B1 Publication Date:
- 07/05/2008
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 16/11/2021
- Renunciation date:
- Revocation date:
- 06/10/2014
- Annulment date:
Owner
- From:
- 16/11/2001
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Agent
- Name:
- VAN MALDEREN MICHEL
- From:
- 20/06/2008
- Address:
- ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- HUTCHINSON Howard Gerard
- Address:
- United States (US)
2
- Name:
- RAZA Ali
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0028429
- Priority Date:
- 22/11/2000
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 31/505;
| Filing date | Document type | Number of pages |
|---|